Intro

This chapter examines the changing role of bariatric surgery amidst the growing use of anti-obesity medications like GLP-1 receptor agonists. Insights from bariatric surgeons reveal a decline in surgery bookings, emphasizing how medical advancements are reshaping treatment approaches for obesity.